First Quadrant’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

First Quadrant’s Portfolio GRTS Stock Details GRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,500	Closed	-$19K	–	547
2021 Q4	$19K	Buy	+1,500	New	+$16.6K	﹤0.01%	478
2021 Q2	–	Sell	-15,900	Closed	-$150K	–	604
2021 Q1	$150K	Buy	+15,900	New	+$219K	0.02%	386

Other funds holding GRTS

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

First Quadrant's GRTS Position: Q1 2022 in Review

First Quadrant sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q1 2022, closing a stake of 1,500 shares — an estimated $19K sold.

First Quadrant first reported a position in GRTS in Q1 2021 and held it in 2 quarters. The position peaked at $150K in Q1 2021. 117 funds tracked by Wall St. Rank hold GRTS as of Q1 2022.

First Quadrant reported no remaining Gritstone bio, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
First Quadrant sold 1,500 Gritstone bio, Inc. Common Stock shares in Q1 2022, an estimated $19K.
First Quadrant first reported a position in Gritstone bio, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
First Quadrant's Gritstone bio, Inc. Common Stock position peaked at $150K in Q1 2021.
117 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q1 2022.

Based on First Quadrant's 13F filing for Q1 2022, filed 21 Apr 2022.